<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.5//EN" "ep-patent-document-v1-5.dtd">
<ep-patent-document id="EP11738472B8W1" file="EP11738472W1B8.xml" lang="en" country="EP" doc-number="2566847" kind="B8" correction-code="W1" date-publ="20190327" status="c" dtd-version="ep-patent-document-v1-5">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>BDM Ver 0.1.63 (23 May 2017) -  2999001/0</B007EP></eptags></B000><B100><B110>2566847</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20190327</date></B140><B150><B151>W1</B151><B153>73</B153><B155><B1551>de</B1551><B1552>Bibliographie</B1552><B1551>en</B1551><B1552>Bibliography</B1552><B1551>fr</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>11738472.7</B210><B220><date>20110506</date></B220><B240><B241><date>20121205</date></B241><B242><date>20160226</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>1265CH2010</B310><B320><date>20100506</date></B320><B330><ctry>IN</ctry></B330></B300><B400><B405><date>20190327</date><bnum>201913</bnum></B405><B430><date>20130313</date><bnum>201311</bnum></B430><B450><date>20181107</date><bnum>201845</bnum></B450><B452EP><date>20180831</date></B452EP><B480><date>20190327</date><bnum>201913</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>C07D 209/14        20060101AFI20111122BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>C07D 213/75        20060101ALI20111122BHEP        </text></classification-ipcr><classification-ipcr sequence="3"><text>C07D 213/81        20060101ALI20111122BHEP        </text></classification-ipcr><classification-ipcr sequence="4"><text>C07D 213/56        20060101ALI20111122BHEP        </text></classification-ipcr><classification-ipcr sequence="5"><text>C07D 241/24        20060101ALI20111122BHEP        </text></classification-ipcr><classification-ipcr sequence="6"><text>C07D 307/79        20060101ALI20111122BHEP        </text></classification-ipcr><classification-ipcr sequence="7"><text>C07D 317/58        20060101ALI20111122BHEP        </text></classification-ipcr><classification-ipcr sequence="8"><text>C07D 319/18        20060101ALI20111122BHEP        </text></classification-ipcr><classification-ipcr sequence="9"><text>C07C 233/66        20060101ALI20111122BHEP        </text></classification-ipcr><classification-ipcr sequence="10"><text>C07C 235/84        20060101ALI20111122BHEP        </text></classification-ipcr><classification-ipcr sequence="11"><text>A61K  31/167       20060101ALI20111122BHEP        </text></classification-ipcr><classification-ipcr sequence="12"><text>A61K  31/44        20060101ALI20111122BHEP        </text></classification-ipcr><classification-ipcr sequence="13"><text>A61K  31/4965      20060101ALI20111122BHEP        </text></classification-ipcr><classification-ipcr sequence="14"><text>A61P  19/02        20060101ALI20111122BHEP        </text></classification-ipcr><classification-ipcr sequence="15"><text>A61P  35/00        20060101ALI20111122BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>NEUARTIGE IMMUNMODULATOREN UND ENTZÜNDUNGSHEMMENDE VERBINDUNGEN</B542><B541>en</B541><B542>NOVEL IMMUNOMODULATOR AND ANTI INFLAMMATORY COMPOUNDS</B542><B541>fr</B541><B542>NOUVEAUX COMPOSÉS IMMUNOMODULATEURS ET ANTI-INFLAMMATOIRES</B542></B540><B560><B561><text>EP-A1- 2 135 610</text></B561><B561><text>WO-A1-2011/026107</text></B561><B561><text>WO-A2-03/006425</text></B561><B561><text>DE-C- 887 501</text></B561><B561><text>US-A- 2 474 893</text></B561><B562><text>SHINJI ANDO ET AL: "Substituent shielding parameters of fluorine-19 NMR on polyfluoroaromatic compounds dissolved in dimethyl sulphoxide-d6", MAGNETIC RESONANCE IN CHEMISTRY, vol. 33, no. 8, 1 August 1995 (1995-08-01) , pages 639-645, XP55005140, ISSN: 0749-1581, DOI: 10.1002/mrc.1260330805</text></B562><B562><text>SERCHENKOVA S V ET AL: "IR spectroscopic study of compounds of benzimide-amido-acid series", POLYMER SCIENCE U.S.S.R, PERGAMON, vol. 18, no. 8, 1 January 1976 (1976-01-01), pages 2133-2141, XP024123389, ISSN: 0032-3950, DOI: 10.1016/0032-3950(76)90402-0 [retrieved on 1976-01-01]</text></B562><B562><text>RUSCHIG H ET AL: "2,6-DIHYDROXYBENZOESAEUREDERIVATE ALS ANTHELMINTHIKA//2,6-DIHYDROXYBE NZOIC ACID DERIVATIVES AS ANTHELIMINTICS", ARZNEIMITTEL FORSCHUNG. DRUG RESEARCH, ECV EDITIO CANTOR VERLAG, AULENDORF, DE, vol. 23, no. 12, 1 January 1973 (1973-01-01), pages 1745-1758, XP009044195, ISSN: 0004-4172</text></B562><B562><text>HARTMANN R W ET AL: "SYNTHESIS AND AROMATASE INHIBITION OF 3-CYCLOALKYL-SUBSTITUTED 3-(4-AMINOPHENYL)PIPERIDINE-2,6-DIONES", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 35, no. 12, 12 June 1992 (1992-06-12) , pages 2210-2214, XP000615592, ISSN: 0022-2623, DOI: 10.1021/JM00090A010</text></B562><B562><text>JOHN S. SWENTON ET AL: "Preparation of quinol N-acyl- and quinol ether imines via anodic oxidation of para-substituted anilide derivatives", THE JOURNAL OF ORGANIC CHEMISTRY, vol. 58, no. 21, 1 October 1993 (1993-10-01), pages 5607-5614, XP55005169, ISSN: 0022-3263, DOI: 10.1021/jo00073a016</text></B562></B560></B500><B700><B720><B721><snm>MUTHUPPALANIAPPAN, Meyyappan</snm><adr><str>c/o Incozen Therapeutics Pvt. Ltd.
"Spectrum" Discovery Zone
SP Biotech Park Phase I
Shameerpet</str><city>Hyderabad 500 078</city><ctry>IN</ctry></adr></B721><B721><snm>BHAVAR, Prashnant, Kashinath</snm><adr><str>c/o Incozen Therapeutics Pvt. Ltd.
"Spectrum" Discovery Zone
SP Biotech Park Phase I
Shameerpet</str><city>Hyderabad 500 078</city><ctry>IN</ctry></adr></B721><B721><snm>VISWANADHA, Srikant</snm><adr><str>c/o Incozen Therapeutics Pvt. Ltd.
"Spectrum" Discovery Zone
SP Biotech Park Phase I
Shameerpet</str><city>Hyderabad 500 078</city><ctry>IN</ctry></adr></B721><B721><snm>VAKKALANKA, Swaroop, Kumar, V.S.</snm><adr><str>Fritz Courvoisier 40</str><city>CH-2300 La Chaux-de-Fonds</city><ctry>IN</ctry></adr></B721><B721><snm>MERIKAPUDI, Gayatri, Swaroop</snm><adr><str>c/o Incozen Therapeutics Pvt. Ltd.
"Spectrum" Discovery Zone
SP Biotech Park Phase I
Shameerpet</str><city>Hyderabad 500 078</city><ctry>IN</ctry></adr></B721></B720><B730><B731><snm>Incozen Therapeutics Pvt. Ltd.</snm><iid>101798940</iid><irf>EP2667.13</irf><adr><str>"Spectrum" Discovery Zone 
SP Biotech Park, Phase I 
Shameerpet</str><city>Hyderabad 500 078</city><ctry>IN</ctry></adr></B731><B731><snm>Rhizen Pharmaceuticals S.A.</snm><iid>101241817</iid><irf>EP2667.13</irf><adr><str>Fritz Courvoisier 40</str><city>2300 La Chaux de Fonds</city><ctry>CH</ctry></adr></B731></B730><B740><B741><snm>Pons</snm><iid>101597830</iid><adr><str>Glorieta Ruben Dario 4</str><city>28010 Madrid</city><ctry>ES</ctry></adr></B741></B740></B700><B800><B840><ctry>AL</ctry><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>MK</ctry><ctry>MT</ctry><ctry>NL</ctry><ctry>NO</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>RS</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>SM</ctry><ctry>TR</ctry></B840><B860><B861><dnum><anum>IB2011000959</anum></dnum><date>20110506</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2011138665</pnum></dnum><date>20111110</date><bnum>201145</bnum></B871></B870></B800></SDOBI>
</ep-patent-document>
